A Nutritional Intervention in Police Officers

The proposed study seeks to test the effect of a plant-based dietary intervention on cardiovascular risk factors in police officers.

Study Overview

Detailed Description

This study tests the hypotheses that a low-fat, plant-based (vegan) diet improves body weight, plasma lipid concentrations, blood pressure, and, in individuals with type 2 diabetes, glycemic control, that a low-fat, plant-based diet improves health-related quality of life as measured by the Medical Outcomes Study Short Form 36-Item Health Survey (SF-36), and that a low-fat, plant-based diet improves mood, as measured by the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R).

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • District of Columbia
      • Washington, District of Columbia, United States, 20016
        • Physicians Committee for Responsible Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Men and women at least 18 years
  2. Body mass index ≥ 25 kg/m2 and/or a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥ 126 mg/dl on two occasions or a prior physician's diagnosis of type 2 diabetes
  3. Currently an employee of the Metropolitan Police Department of the District of Columbia
  4. Ability and willingness to participate in all components of the study
  5. A willingness to be randomly assigned to either study group

Exclusion Criteria:

  1. Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
  2. Use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion)
  3. Pregnancy
  4. Unstable medical or psychiatric illness
  5. Likely to be disruptive in group sessions (as determined by research staff)
  6. Already following a low-fat, vegan diet
  7. Lack of English fluency
  8. Inability or unwillingness to participate in all components of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vegan Group
Participants in the intervention group will follow a low-fat, plant-based diet for 14 weeks, and will attend nutrition classes in the form of a weekly support group.
Weekly instructions will be given to the participants in the intervention group about following vegan diet.
Other Names:
  • Vegan Group
Active Comparator: Control Group
The control group will follow an unrestricted diet with no instruction.
Unrestricted diet with no instruction.
Other Names:
  • Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Weight
Time Frame: Changes in body weight from Baseline at 14 weeks
body weight will be measured to the nearest 0.1 kg, using a digital scale.
Changes in body weight from Baseline at 14 weeks
Plasma lipid concentrations
Time Frame: Changes in plasma lipid concentrations from Baseline at 14 weeks
will be measured using the Olympus Cholesterol Reagent on Olympus Chemistry Analyzers to assess changes in plasma lipid concentrations.
Changes in plasma lipid concentrations from Baseline at 14 weeks
Blood pressure
Time Frame: Changes in blood pressure from Baseline at 14 weeks
Blood pressure will be measured at each assessment
Changes in blood pressure from Baseline at 14 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life and Mood
Time Frame: Change in quality of life from Baseline at 4 months
Measured by a Modified Health Assessment Questionnaire (MHAQ). The questionnaire measures the difficulty level of performing 8 different activities. A score of 0 = the activity can be performed without difficulty. A score of 3 = the activity cannot be performed. The MHAQ is calculated as the average of these scores.
Change in quality of life from Baseline at 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Neal D Barnard, M.D., President

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Estimated)

May 1, 2025

Study Completion (Estimated)

May 1, 2025

Study Registration Dates

First Submitted

January 7, 2016

First Submitted That Met QC Criteria

January 7, 2016

First Posted (Estimated)

January 11, 2016

Study Record Updates

Last Update Posted (Actual)

November 3, 2023

Last Update Submitted That Met QC Criteria

November 2, 2023

Last Verified

November 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Plant-based diet

3
Subscribe